<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Omega</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id>
    <journal-id journal-id-type="publisher-id">ao</journal-id>
    <journal-id journal-id-type="coden">acsodf</journal-id>
    <journal-title-group>
      <journal-title>ACS Omega</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2470-1343</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7097909</article-id>
    <article-id pub-id-type="doi">10.1021/acsomega.9b03848</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Peptide Combination Generator: a Tool for Generating
Peptide Combinations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Ali</surname>
          <given-names>Naseem</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Shamoon</surname>
          <given-names>Arzoo</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Yadav</surname>
          <given-names>Neelesh</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath4">
        <name>
          <surname>Sharma</surname>
          <given-names>Tanuj</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
      </contrib>
      <aff id="AFF-d7e61-autogenerated">Bioinformatics Center, <institution>Forest
Research Institute</institution>, Dehradun, Uttrakhand 248006, <country>India</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>E-mail: <email>tanush84@gmail.com</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>03</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>24</day>
      <month>03</month>
      <year>2020</year>
    </pub-date>
    <volume>5</volume>
    <issue>11</issue>
    <fpage>5781</fpage>
    <lpage>5783</lpage>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>11</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>06</day>
        <month>02</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2020 American Chemical Society</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>American Chemical Society</copyright-holder>
      <license>
        <license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao9b03848_0003" id="ab-tgr1"/>
      </p>
      <p>Peptides
are used as reagents both for basic research and diagnostic
purposes. Therefore, there is a need for novel methods for the design
of peptide molecules with a particular specific physiochemical profile.
The properties of the peptides are governed by the nature of amino
acids constituting the peptide. There is a lack of a web server or
tools which could predict all the possible combinations of the peptides
generated because of the combinations of amino acids based on the
physiochemical properties. We have developed a peptide combination
generator (PepCoGen), a web server for generating all the possible
combinations of peptides by varying the amino acids having similar
physiochemical properties at a particular position. It also predicts
other properties of the peptides including molecular weight, charge,
solubility, hydrophobic plot, and isoelectric point, and random three-dimensional
models for each generated combination.</p>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ao9b03848</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ao9b03848</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>In
the past decade, peptides have gained diverse applications in
both medicine and biotechnology; moreover, the therapeutic peptide
research has experienced revolution because of commercial reasons.
Peptide sequences are constituents of bigger proteins, where they
assist in molecular recognition and various biological functions by
acting as precursors for proteins,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> alkaloids,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> hormones,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> anti-malarial
agents,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> antimicrobial agents,<sup><xref ref-type="bibr" rid="ref5">5</xref>−<xref ref-type="bibr" rid="ref7">7</xref></sup> anti-oxidants,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> anti-neurodegenerative,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> immunogens,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> and
many more.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Inhibition of protein–protein
interactions by peptides and thereby therapeutic intervention of various
disease-causing pathways have been the key for peptide drug design.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Moreover, owing to their high specificity, safety,
tolerability, efficacy, and excellent pharmacological profile, peptides
seem to be ideal drug leads.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> There are
more than 60 FDA-approved peptide drugs in the market, and more than
150 peptide drugs are in clinical trials and more than 500 therapeutic
peptides in preclinical development.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Numerous peptides
including insulin, calcitonin, oxytocin, and vasopressin have been
used as therapeutic peptides.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Similarly, peptides
from snake venom have been used for therapeutic purposes.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> There has been an increase in the development
of combinatorial methods for discovery of membrane-active peptides<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and cell-permeable bicyclic peptides.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Similarly, there has also been an increase in
computational methods for the prediction of therapeutic peptides,<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> peptide structure,<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> peptide docking,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and peptide binding.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Peptide libraries are routinely used as a powerful
tool in biological research.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> They provide
a quick and economical solution for a wide range of bioactivity screening
purposes and identifying bioactive peptides. Dedicated libraries are
ideal for “T-cell epitope mapping and searching”. Overlapping
linear peptide libraries provide a rapid route to mapping of the linear
or complex epitope of the antibody. Peptide libraries are also used
as enzyme substrates, ligands, or inhibitors in biochemical studies.
The 20 amino acids can be differentiated into six broad groups, namely,
hydrophobic (aliphatic), aromatic, basic, acidic, unique, and polar
uncharged based on their physiochemical properties<sup><xref ref-type="bibr" rid="ref26">26</xref>−<xref ref-type="bibr" rid="ref28">28</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Table S1</ext-link>). Currently, there is no standalone
tool or web server, which could generate all the possible combination
of the peptides by varying or mutating the amino acids with other
residues having similar properties at a particular position in the
peptide sequence. To predict all such combinations for the peptide,
we have developed a user-friendly web server, which can be freely
accessed at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.bicfri.in/pepcogen/">https://www.bicfri.in/pepcogen/</uri>. The front end of the web server is illustrated in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Image indicates the main
web server front page, which can be used
to access both basic and advanced modules of the web server.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao9b03848_0001" id="gr1" position="float"/>
    </fig>
  </sec>
  <sec id="sec2">
    <title>Results and Discussion</title>
    <p>The basic
module only calculates the total combinations along with
the peptide sequence, while the advanced modules calculate the physiochemical
properties for all the combinations as well. Peptides of length 4
to 21 residues have been explored, as mostly the wet lab synthesis
of peptides has been focused on developing peptides of these lengths.
The peptide length can be increased, but the computational cost of
calculating all the physiochemical properties was found to be high
for such peptides. Therefore, we restricted the length of peptides
to this range. In both basic and advanced modules, after initially
selecting the sequence of the peptide fragment ranging from 4 to 21
amino acids (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figures S1–S3</ext-link>),
a drop-down menu will pop up asking the user to select the desired
amino acids having the selected physiochemical property for each position
in the peptide (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S4</ext-link>). After submitting
the request on the front end, all the possible combinations of the
peptide sequences based on the selected properties are calculated
for both the modules (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S5</ext-link>). For example,
for calculating the number of combinations for the peptide having
sequence length 6 and having the possibility of acidic amino acids
for positions 1 and 2, basic amino acids for positions 3 and 4, and
hydrophobic amino acids for positions 5 and 6, the total possible
combinations generated were 900, which were displayed on the browser
window of the client end. For the advanced module (which is limited
for generating combinations of up to 0.1 million), all the combinations
are listed along with the calculated physiochemical properties including
molecular weight, isoelectric point, charge, solubility, and hydropathy
index, and a random 3D model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S6</ext-link>). For instance, for calculating the combinations for the peptide
with length 5, having the possibility of hydrophobic residues at all
positions, we generated 3125 combinations (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S7</ext-link>). The hydropathy index is displaced in a new window along
with its average value (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S8</ext-link>). The
models can be generated, by clicking on the model icon in the corresponding
tab, in a separate window using the JSmol library (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Figure S9</ext-link>). However, the 3D models were generated accurately
for the peptides having a length of up to 8 amino acids. Methods described
previously were found to be more accurate<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> and can be used for generating models using the string format generated
for each combination.</p>
  </sec>
  <sec id="sec3">
    <title>Conclusions</title>
    <p>We introduce a user-friendly
web server tool, peptide combination
generator (PepCoGen), which is the first freeware to assist the researchers
in creating all the possible combinations of the peptide sequence
by the variation of amino acids having similar physiochemical properties.
The peptide combinations generated for a particular peptide sequence
can be used by the researchers in making crucial decisions for selecting
peptide sequences. The decision for selecting the peptides could be
based on their molecular weight, charge, isoelectric point, and hydropathy
index. Furthermore, by conserving the critical residues, all the possible
combinations based on the physiochemical profile can be used to design
analogues for sequence optimizations. Custom peptide libraries can
be shortlisted, which have widespread applications in identifying
critical amino acid residues, designing analogues, identifications
of more potent peptide-based drugs, and many more. The web server
could be used for the design of virtual peptide library databases,
which further have numerous applications.</p>
  </sec>
  <sec id="sec4">
    <title>Computational Methods</title>
    <p>The web server “PepCoGen” is organized as the REST
architecture, with the front end of the server for the user interface
and the back end for the algorithm scripts. The front end was designed
using HTML, CSS, JQUERY, AJAX, and BOOTSTRAP, while the back end scripts
were written in PHP. The physiochemical properties of the peptides
including molecular mass, charge, solubility, and isoelectric point
(at pH 7) were calculated using scripts 1, 2, 3, and 4, respectively,
described in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Supporting Information</ext-link> (scripts s1, s2, s3, and s4). The hydropathy index was calculated
using script 5, described in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">Supporting Information</ext-link> (script s5). The models were generated using JSmol plugin.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> PepCoGen was implemented in PHP language, and
the complete workflow has been described in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>. PepCoGen is an easy-to-use tool to generate
combinations for peptide lengths ranging from 4 to 21 residues and
has widespread practical applications. The tool has been divided into
basic and advanced modules. The basic module only calculates and reports
all the combinations in the screen. The advanced module can calculate
combinations up to 0.1 million peptides, along with the other features
including molecular weight, charge, solubility, isoelectric point,
and hydropathy index, and generate a random 3D model for each peptide.
For calculating the isoelectric point, computationally optimized dissociation
constant (p<italic>K</italic><sub>a</sub>) values of amino acids were
used.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> For calculating the hydropathy
index values, the Hoops and Woods method was used as the values calculated
could be useful in developing synthetic peptide immunogens and for
understanding the relationship of the peptide sequence and its interaction
with macromolecules.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Models for each
peptide were built using JSmol plugin. For the advanced module, the
results can be viewed in the screen in batches of 10, 25, 50, and
100 per page. The results can also be downloaded in the excel sheet
and pdf format.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Description of the workflow implemented in web.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao9b03848_0002" id="gr2" position="float"/>
    </fig>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.9b03848?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.9b03848</ext-link>.<list id="silist" list-type="simple"><list-item><p>Classification table of
various amino acids based on
their physiochemical properties, screenshots of the different modules
and how to use them for inferring results, and different scripts used
for calculating various physiochemical properties (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03848/suppl_file/ao9b03848_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao9b03848_si_001.pdf">
        <caption>
          <p>ao9b03848_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="funding-statement" id="notes2">
    <p>This study was
supported by the Department of Biotechnology, Government of India.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d7e320-autogenerated">
    <p>The authors declare
no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors are
grateful to both FRI, Dehradun,
and Department of Biotechnology, India.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Trimaille</surname><given-names>T.</given-names></name>; <name><surname>Mabrouk</surname><given-names>K.</given-names></name>; <name><surname>Monnier</surname><given-names>V.</given-names></name>; <name><surname>Charles</surname><given-names>L.</given-names></name>; <name><surname>Bertin</surname><given-names>D.</given-names></name>; <name><surname>Gigmes</surname><given-names>D.</given-names></name><article-title>SG1-Functionalized
peptides as precursors for polymer-peptide
conjugates: A straightforward Approach</article-title>. <source>Macromolecules</source><year>2010</year>, <volume>43</volume>, <fpage>4864</fpage>–<lpage>4870</lpage>. <pub-id pub-id-type="doi">10.1021/ma100598d</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Giacomelli</surname><given-names>S. R.</given-names></name>; <name><surname>Maldaner</surname><given-names>G.</given-names></name>; <name><surname>Gonzaga</surname><given-names>W. A.</given-names></name>; <name><surname>Garcia</surname><given-names>C. M.</given-names></name>; <name><surname>da Silva</surname><given-names>U. F.</given-names></name>; <name><surname>Dalcol</surname><given-names>I. I.</given-names></name>; <name><surname>Morel</surname><given-names>A. F.</given-names></name><article-title>Cyclic peptide alkaloids from the
bark of Discaria americana</article-title>. <source>Phytochemistry</source><year>2004</year>, <volume>65</volume>, <fpage>933</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/j.phytochem.2004.02.006</pub-id>.<pub-id pub-id-type="pmid">15081298</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Hutchinson</surname><given-names>J. A.</given-names></name>; <name><surname>Burholt</surname><given-names>S.</given-names></name>; <name><surname>Hamley</surname><given-names>I. W.</given-names></name><article-title>Peptide
hormones and lipopeptides:
from self-assembly to therapeutic applications</article-title>. <source>J. Pept. Sci.</source><year>2017</year>, <volume>23</volume>, <fpage>82</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/psc.2954</pub-id>.<pub-id pub-id-type="pmid">28127868</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Fagundez</surname><given-names>C.</given-names></name>; <name><surname>Sellanes</surname><given-names>D.</given-names></name>; <name><surname>Serra</surname><given-names>G.</given-names></name><article-title>Synthesis
of Cyclic Peptides as Potential
Anti-Malarials</article-title>. <source>ACS Comb. Sci.</source><year>2018</year>, <volume>20</volume>, <fpage>212</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1021/acscombsci.7b00154</pub-id>.<pub-id pub-id-type="pmid">29446619</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Sierra</surname><given-names>J. M.</given-names></name>; <name><surname>Fusté</surname><given-names>E.</given-names></name>; <name><surname>Rabanal</surname><given-names>F.</given-names></name>; <name><surname>Vinuesa</surname><given-names>T.</given-names></name>; <name><surname>Viñas</surname><given-names>M.</given-names></name><article-title>An overview
of antimicrobial peptides and the latest advances in their development</article-title>. <source>Expert Opin. Biol. Ther.</source><year>2017</year>, <volume>17</volume>, <fpage>663</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1080/14712598.2017.1315402</pub-id>.<pub-id pub-id-type="pmid">28368216</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Juretić</surname><given-names>D.</given-names></name>; <name><surname>Vukicević</surname><given-names>D.</given-names></name>; <name><surname>Ilić</surname><given-names>N.</given-names></name>; <name><surname>Antcheva</surname><given-names>N.</given-names></name>; <name><surname>Tossi</surname><given-names>A.</given-names></name><article-title>Computational
design of highly selective antimicrobial peptides</article-title>. <source>J. Chem. Inf. Model.</source><year>2009</year>, <volume>49</volume>, <fpage>2873</fpage>–<lpage>2882</lpage>. <pub-id pub-id-type="doi">10.1021/ci900327a</pub-id>.<pub-id pub-id-type="pmid">19947578</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Vishnepolsky</surname><given-names>B.</given-names></name>; <name><surname>Gabrielian</surname><given-names>A.</given-names></name>; <name><surname>Rosenthal</surname><given-names>A.</given-names></name>; <name><surname>Hurt</surname><given-names>D. E.</given-names></name>; <name><surname>Tartakovsky</surname><given-names>M.</given-names></name>; <name><surname>Managadze</surname><given-names>G.</given-names></name>; <name><surname>Grigolava</surname><given-names>M.</given-names></name>; <name><surname>Makhatadze</surname><given-names>G. I.</given-names></name>; <name><surname>Pirtskhalava</surname><given-names>M.</given-names></name><article-title>Predictive Model of Linear Antimicrobial Peptides Active
against Gram-Negative Bacteria</article-title>. <source>J. Chem. Inf.
Model.</source><year>2018</year>, <volume>58</volume>, <fpage>1141</fpage>–<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00118</pub-id>.<pub-id pub-id-type="pmid">29716188</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Kobayashi</surname><given-names>K.</given-names></name>; <name><surname>Maehata</surname><given-names>Y.</given-names></name>; <name><surname>Okada</surname><given-names>Y.</given-names></name>; <name><surname>Kusubata</surname><given-names>M.</given-names></name>; <name><surname>Hattori</surname><given-names>S.</given-names></name>; <name><surname>Tanaka</surname><given-names>K.</given-names></name>; <name><surname>Miyamoto</surname><given-names>C.</given-names></name>; <name><surname>Yoshino</surname><given-names>F.</given-names></name>; <name><surname>Yoshida</surname><given-names>A.</given-names></name>; <name><surname>Tokutomi</surname><given-names>F.</given-names></name>; <name><surname>Wada-Takahashi</surname><given-names>S.</given-names></name>; <name><surname>Komatsu</surname><given-names>T.</given-names></name>; <name><surname>Otsuka</surname><given-names>T.</given-names></name>; <name><surname>Takahashi</surname><given-names>S.-S.</given-names></name>; <name><surname>Lee</surname><given-names>M.-C. -I.</given-names></name><article-title>Medical-grade collagen peptide in
injectables provides antioxidant protection</article-title>. <source>Pharm. Dev. Technol.</source><year>2015</year>, <volume>20</volume>, <fpage>219</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.3109/10837450.2013.860547</pub-id>.<pub-id pub-id-type="pmid">24286241</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Goyal</surname><given-names>D.</given-names></name>; <name><surname>Shuaib</surname><given-names>S.</given-names></name>; <name><surname>Mann</surname><given-names>S.</given-names></name>; <name><surname>Goyal</surname><given-names>B.</given-names></name><article-title>Rationally Designed
Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ)
Aggregation: Potential Therapeutics of Alzheimer’s Disease</article-title>. <source>ACS Comb. Sci.</source><year>2017</year>, <volume>19</volume>, <fpage>55</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1021/acscombsci.6b00116</pub-id>.<pub-id pub-id-type="pmid">28045249</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Lee</surname><given-names>B.-S.</given-names></name>; <name><surname>Huang</surname><given-names>J.-S.</given-names></name>; <name><surname>Jayathilaka</surname><given-names>L. P.</given-names></name>; <name><surname>Lee</surname><given-names>J.</given-names></name>; <name><surname>Gupta</surname><given-names>S.</given-names></name><article-title>Antibody Production
with Synthetic Peptides</article-title>. <source>Methods Mol. Biol.</source><year>2016</year>, <volume>1474</volume>, <fpage>25</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-6352-2_2</pub-id>.<pub-id pub-id-type="pmid">27515072</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Cui</surname><given-names>W.</given-names></name>; <name><surname>Wei</surname><given-names>Z.</given-names></name>; <name><surname>Chen</surname><given-names>Q.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Geng</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Hou</surname><given-names>T.</given-names></name>; <name><surname>Ji</surname><given-names>M.</given-names></name><article-title>Structure-based design
of peptides against G3BP with cytotoxicity on tumor cells</article-title>. <source>J. Chem. Inf. Model.</source><year>2010</year>, <volume>50</volume>, <fpage>380</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1021/ci900404p</pub-id>.<pub-id pub-id-type="pmid">20180532</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Chang</surname><given-names>Y. S.</given-names></name>; <name><surname>Graves</surname><given-names>B.</given-names></name>; <name><surname>Guerlavais</surname><given-names>V.</given-names></name>; <name><surname>Tovar</surname><given-names>C.</given-names></name>; <name><surname>Packman</surname><given-names>K.</given-names></name>; <name><surname>To</surname><given-names>K. H.</given-names></name>; <name><surname>Olson</surname><given-names>K. A.</given-names></name>; <name><surname>Kesavan</surname><given-names>K.</given-names></name>; <name><surname>Gangurde</surname><given-names>P.</given-names></name>; <name><surname>Mukherjee</surname><given-names>A.</given-names></name>; <name><surname>Baker</surname><given-names>T.</given-names></name>; <name><surname>Darlak</surname><given-names>K.</given-names></name>; <name><surname>Elkin</surname><given-names>C.</given-names></name>; <name><surname>Filipovic</surname><given-names>Z.</given-names></name>; <name><surname>Qureshi</surname><given-names>F. Z.</given-names></name>; <name><surname>Cai</surname><given-names>H.</given-names></name>; <name><surname>Berry</surname><given-names>P.</given-names></name>; <name><surname>Feyfant</surname><given-names>E.</given-names></name>; <name><surname>Shi</surname><given-names>X. E.</given-names></name>; <name><surname>Horstick</surname><given-names>J.</given-names></name>; <name><surname>Annis</surname><given-names>D. A.</given-names></name>; <name><surname>Manning</surname><given-names>A. M.</given-names></name>; <name><surname>Fotouhi</surname><given-names>N.</given-names></name>; <name><surname>Nash</surname><given-names>H.</given-names></name>; <name><surname>Vassilev</surname><given-names>L. T.</given-names></name>; <name><surname>Sawyer</surname><given-names>T. K.</given-names></name><article-title>Stapled
α-helical peptide drug development: a
potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2013</year>, <volume>110</volume>, <fpage>E3445</fpage>–<lpage>E3454</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1303002110</pub-id>.<pub-id pub-id-type="pmid">23946421</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Fosgerau</surname><given-names>K.</given-names></name>; <name><surname>Hoffmann</surname><given-names>T.</given-names></name><article-title>Peptide therapeutics: current status and future directions</article-title>. <source>Drug Discovery Today</source><year>2015</year>, <volume>20</volume>, <fpage>122</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2014.10.003</pub-id>.<pub-id pub-id-type="pmid">25450771</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Kaspar</surname><given-names>A. A.</given-names></name>; <name><surname>Reichert</surname><given-names>J. M.</given-names></name><article-title>Future directions
for peptide therapeutics development</article-title>. <source>Drug Discovery
Today</source><year>2013</year>, <volume>18</volume>, <fpage>807</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2013.05.011</pub-id>.<pub-id pub-id-type="pmid">23726889</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Carney</surname><given-names>R. P.</given-names></name>; <name><surname>Thillier</surname><given-names>Y.</given-names></name>; <name><surname>Kiss</surname><given-names>Z.</given-names></name>; <name><surname>Sahabi</surname><given-names>A.</given-names></name>; <name><surname>Heleno Campos</surname><given-names>J. C.</given-names></name>; <name><surname>Knudson</surname><given-names>A.</given-names></name>; <name><surname>Liu</surname><given-names>R.</given-names></name>; <name><surname>Olivos</surname><given-names>D.</given-names></name>; <name><surname>Saunders</surname><given-names>M.</given-names></name>; <name><surname>Tian</surname><given-names>L.</given-names></name>; <name><surname>Lam</surname><given-names>K. S.</given-names></name><article-title>Combinatorial
Library Screening with
Liposomes for Discovery of Membrane Active Peptides</article-title>. <source>ACS Comb. Sci.</source><year>2017</year>, <volume>19</volume>, <fpage>299</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1021/acscombsci.6b00182</pub-id>.<pub-id pub-id-type="pmid">28378995</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>de
Barros</surname><given-names>E.</given-names></name>; <name><surname>Gonçalves</surname><given-names>R. M.</given-names></name>; <name><surname>Cardoso</surname><given-names>M. H.</given-names></name>; <name><surname>Santos</surname><given-names>N. C.</given-names></name>; <name><surname>Franco</surname><given-names>O. L.</given-names></name>; <name><surname>Cândido</surname><given-names>E. S.</given-names></name><article-title>Snake Venom Cathelicidins as Natural
Antimicrobial Peptides</article-title>. <source>Front. Pharmacol.</source><year>2019</year>, <volume>10</volume>, <fpage>1415</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.01415</pub-id>.<pub-id pub-id-type="pmid">31849667</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Trinh</surname><given-names>T. B.</given-names></name>; <name><surname>Upadhyaya</surname><given-names>P.</given-names></name>; <name><surname>Qian</surname><given-names>Z.</given-names></name>; <name><surname>Pei</surname><given-names>D.</given-names></name><article-title>Discovery
of a Direct
Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable
Bicyclic Peptides</article-title>. <source>ACS Comb. Sci.</source><year>2016</year>, <volume>18</volume>, <fpage>75</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1021/acscombsci.5b00164</pub-id>.<pub-id pub-id-type="pmid">26645887</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Lau</surname><given-names>J. L.</given-names></name>; <name><surname>Dunn</surname><given-names>M. K.</given-names></name><article-title>Therapeutic peptides: Historical
perspectives, current
development trends, and future directions</article-title>. <source>Bioorg.
Med. Chem.</source><year>2018</year>, <volume>26</volume>, <fpage>2700</fpage>–<lpage>2707</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2017.06.052</pub-id>.<pub-id pub-id-type="pmid">28720325</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Freire</surname><given-names>J. M.</given-names></name>; <name><surname>Almeida Dias</surname><given-names>S.</given-names></name>; <name><surname>Flores</surname><given-names>L.</given-names></name>; <name><surname>Veiga</surname><given-names>A. S.</given-names></name>; <name><surname>Castanho</surname><given-names>M. A. R. B.</given-names></name><article-title>Mining
viral proteins for antimicrobial and cell-penetrating drug delivery
peptides</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>2252</fpage>–<lpage>2256</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv131</pub-id>.<pub-id pub-id-type="pmid">25725499</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Sharma</surname><given-names>T.</given-names></name>; <name><surname>Siddiqi</surname><given-names>M. I.</given-names></name><article-title>In silico identification and design
of potent peptide
inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95)</article-title>. <source>J. Biomol. Struct. Dyn.</source><year>2019</year>, <volume>37</volume>, <fpage>1241</fpage>–<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2018.1454851</pub-id>.<pub-id pub-id-type="pmid">29557723</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Singh</surname><given-names>H.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Singh</surname><given-names>B.</given-names></name>; <name><surname>Kumaran</surname><given-names>S.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>PEPstrMOD: structure
prediction of peptides containing natural, non-natural and modified
residues</article-title>. <source>Biol. Direct</source><year>2015</year>, <volume>10</volume>, <fpage>73</fpage><pub-id pub-id-type="doi">10.1186/s13062-015-0103-4</pub-id>.<pub-id pub-id-type="pmid">26690490</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Lamiable</surname><given-names>A.</given-names></name>; <name><surname>Thevenet</surname><given-names>P.</given-names></name>; <name><surname>Tufféry</surname><given-names>P.</given-names></name><article-title>A critical
assessment of hidden markov
model sub-optimal sampling strategies applied to the generation of
peptide 3D models</article-title>. <source>J. Comput. Chem.</source><year>2016</year>, <volume>37</volume>, <fpage>2006</fpage>–<lpage>2016</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.24422</pub-id>.<pub-id pub-id-type="pmid">27317417</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Zhou</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Yan</surname><given-names>Y.</given-names></name>; <name><surname>Jin</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Huang</surname><given-names>S.-Y.</given-names></name><article-title>Hierarchical
Flexible Peptide Docking by Conformer Generation and Ensemble Docking
of Peptides</article-title>. <source>J. Chem. Inf. Model.</source><year>2018</year>, <volume>58</volume>, <fpage>1292</fpage>–<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00142</pub-id>.<pub-id pub-id-type="pmid">29738247</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Yordanov</surname><given-names>V.</given-names></name>; <name><surname>Dimitrov</surname><given-names>I.</given-names></name>; <name><surname>Doytchinova</surname><given-names>I.</given-names></name><article-title>Proteochemometrics-Based
Prediction
of Peptide Binding to HLA-DP Proteins</article-title>. <source>J. Chem.
Inf. Model.</source><year>2018</year>, <volume>58</volume>, <fpage>297</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00026</pub-id>.<pub-id pub-id-type="pmid">28719212</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Marasco</surname><given-names>D.</given-names></name>; <name><surname>Perretta</surname><given-names>G.</given-names></name>; <name><surname>Sabatella</surname><given-names>M.</given-names></name>; <name><surname>Ruvo</surname><given-names>M.</given-names></name><article-title>Past and future perspectives
of synthetic peptide libraries</article-title>. <source>Curr. Protein
Pept. Sci.</source><year>2008</year>, <volume>9</volume>, <fpage>447</fpage>–<lpage>467</lpage>. <pub-id pub-id-type="doi">10.2174/138920308785915209</pub-id>.<pub-id pub-id-type="pmid">18855697</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="weblink" id="cit26"><article-title>Amino Acid Reference, Properties of Common
Amino Acids</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sigmaaldrich.com/lifescience/metabolomics.html">https://www.sigmaaldrich.com/lifescience/metabolomics.html</uri> (accessed
October 15, 2018).</mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="book" id="cit27"><person-group person-group-type="allauthors"><name><surname>Lide</surname><given-names>D. R.</given-names></name></person-group><source>Handbook of Chemistry
and Physics</source>, <edition>72</edition>nd ed.; <publisher-name>CRC Press</publisher-name>: <publisher-loc>Boca Raton, FL</publisher-loc>, <year>1991</year>.</mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="book" id="cit28"><person-group person-group-type="allauthors"><name><surname>Nelson</surname><given-names>D. L.</given-names></name>; <name><surname>Cox</surname><given-names>M. M.</given-names></name></person-group><source>Lehninger Principles
of Biochemistry</source>, <edition>5</edition>th ed.; <publisher-name>W. H. Freeman</publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2008</year>.</mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Hanson</surname><given-names>R.
M.</given-names></name>; <name><surname>Lu</surname><given-names>X.-J.</given-names></name><article-title>DSSR-enhanced
visualization of nucleic acid structures in Jmol</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>W528</fpage>–<lpage>W533</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx365</pub-id>.<pub-id pub-id-type="pmid">28472503</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Kozlowski</surname><given-names>L. P.</given-names></name><article-title>IPC - Isoelectric
Point Calculator</article-title>. <source>Biol. Direct</source><year>2016</year>, <volume>11</volume>, <fpage>55</fpage><pub-id pub-id-type="doi">10.1186/s13062-016-0159-9</pub-id>.<pub-id pub-id-type="pmid">27769290</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Hopp</surname><given-names>T. P.</given-names></name><article-title>Use of
hydrophilicity plotting procedures to identify protein antigenic segments
and other interaction sites</article-title>. <source>Methods Enzymol.</source><year>1989</year>, <volume>178</volume>, <fpage>571</fpage>–<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(89)78040-x</pub-id>.<pub-id pub-id-type="pmid">2481215</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
